pharmaphorum March 21, 2024
Among the many struggles faced by the digital therapeutics industry is the difficulty of designing and running effective clinical trials of digital therapeutics. As a yet young category, they often face uncharted regulatory waters. And the extensive data collection that’s possible with digital therapeutics can become a double-edged sword when it adds cost and complexity to trials.
On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, co-founder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about the often unseen difficulties of validating a digital therapeutic through a clinical trial.
Among other things, they discuss regulatory and reimbursement uncertainties, the dangers of treating digital therapeutics too much like drugs,...
Today's Sponsors
Today's Sponsor